JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 56.02B
Enterprise value 36.95B
Trailing P/E 22.16
Forward P/E 16.56
PEG ratio (5-yr expected) 12.10
Price/sales (ttm)2.75
Price/book (mrq)2.15
Enterprise value/revenue 33.17
Enterprise value/EBITDA 67.10

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-22.08%
S&P500 52-week change 36.72%
52-week high 3154.24
52-week low 386.88
50-day moving average 3112.71
200-day moving average 3121.30

Share statistics

Avg vol (3-month) 3669.01k
Avg vol (10-day) 3517.54k
Shares outstanding 555.35M
Float 50.32M
% held by insiders 12.84%
% held by institutions 196.73%
Shares short (14 Jun 2020) 43.74M
Short ratio (14 Jun 2020) 44.48
Short % of float (14 Jun 2020) 46.93%
Short % of shares outstanding (14 Jun 2020) 46.75%
Shares short (prior month 14 May 2020) 42.99M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020


Profit margin 12.81%
Operating margin (ttm)29.99%

Management effectiveness

Return on assets (ttm)7.82%
Return on equity (ttm)10.12%

Income statement

Revenue (ttm)2.19B
Revenue per share (ttm)38.78
Quarterly revenue growth (yoy)5.20%
Gross profit (ttm)2.03B
EBITDA 978.43M
Net income avi to common (ttm)280.33M
Diluted EPS (ttm)4.91
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)981.6M
Total cash per share (mrq)17.74
Total debt (mrq)1.78B
Total debt/equity (mrq)63.24
Current ratio (mrq)3.83
Book value per share (mrq)50.72

Cash flow statement

Operating cash flow (ttm)847.12M
Levered free cash flow (ttm)416.65M